Literature DB >> 33669

Participation of cysteine and cystine in inactivation of tyrosine aminotransferase in rat liver homogenates.

W T Buckley, L P Milligan.   

Abstract

1. Inactivation of tyrosine aminotransferase was studied in rat liver homogenates. Under an O2 atmosphere with cysteine added, inactivation was rapid after a lag period of approx. 1h, whereas a N2 atmosphere extended the lag period to approx. 3h. 2. Replacement of cysteine with cystine resulted in rapid inactivation both aerobically and anaerobically. 3. Removal of the particulate fraction by centrifuging rat liver homogenates at 13,000g for 9min resulted in an aerobic lag period of 0.5h in the presence of cystine and approx. 3h in the presence of cysteine. 4. It is proposed that the stimulatory effect of cysteine on tyrosine aminotransferase inactivation occurs largely as a result of oxidation to cystine, which appears to be a more directly effective agent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 33669      PMCID: PMC1186253          DOI: 10.1042/bj1760449

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Studies on the conversion of multiple forms of tyrosine aminotransferase in rat liver.

Authors:  J M Rodriguez; H C Pitot
Journal:  Arch Biochem Biophys       Date:  1976-11       Impact factor: 4.013

2.  THE SUBUNITS OF FUMARASE.

Authors:  R L HILL; L KANAREK
Journal:  Brookhaven Symp Biol       Date:  1964-12

3.  Properties of partially purified tyrosine-alpha-ketoglutarate transaminase from rat liver.

Authors:  F T KENNEY
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

4.  [The behavior of inorganic pyrophosphatase, triosephosphate dehydrogenase and glucose-6-phosphate dehydrogenase in oxidation of their essential SH groups].

Authors:  D SCHEUCH; S RAPOPORT
Journal:  Acta Biol Med Ger       Date:  1962

5.  Inactivation and ATP-dependent reactivation of tyrosine aminotransferase in vitro by membrane bound enzymes from rat liver and kidney cortex.

Authors:  W Seubert; H H Hamm
Journal:  Biochem Biophys Res Commun       Date:  1975-07-08       Impact factor: 3.575

6.  Subcellular distribution of a factor inactivating tyrosine aminotransferase. Study of its mechanism and relationship to different forms of the enzyme.

Authors:  M Beneking; H Schmidt; G Weiss
Journal:  Eur J Biochem       Date:  1978-01-02

7.  Stabilization of rat liver tyrosine aminotransferase by tetracycline.

Authors:  R Hannah; M K Sahib
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

8.  Studies on the role of vitamin B6 derivatives in regulating tyrosine alpha-ketoglutarate transaminase activity in vitro and in vivo.

Authors:  D Holten; W D Wicks; F T Kenney
Journal:  J Biol Chem       Date:  1967-03-10       Impact factor: 5.157

9.  Inactivation of tyrosine aminotransferase in neutral homogenates and rat liver slices.

Authors:  F Auricchio; L Mollica; A Liguori
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

10.  Irreversible inactivation of rat liver tyrosine aminotransferase.

Authors:  R D Reynolds; S D Thompson
Journal:  Arch Biochem Biophys       Date:  1974-09       Impact factor: 4.013

View more
  7 in total

1.  Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Mason A Sutherland; Connie A Tenorio; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

2.  Enzyme inactivation via disulphide-thiol exchange as catalysed by a rat liver membrane protein.

Authors:  G L Francis; F J Ballard
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

Review 3.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Authors:  Sean H Adams
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

4.  Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations.

Authors:  Prajwalini Mehere; Qian Han; Justin A Lemkul; Christopher J Vavricka; Howard Robinson; David R Bevan; Jianyong Li
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

5.  Effect of physiological reducing compounds on the inactivation of tyrosine aminotransferase from guinea-pig liver.

Authors:  D Di Cola; G Federici
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

6.  Cysteine-dependent inactivation of hepatic ornithine decarboxylase.

Authors:  Y Murakami; T Kameji; S Hayashi
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

7.  Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness.

Authors:  Diane M Libert; Amy S Nowacki; Marvin R Natowicz
Journal:  PeerJ       Date:  2018-08-31       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.